Change of Insulin Resistance in Hepatitis C Virus-infected Patients Receiving Pegylated Interferon Plus Ribavirin

被引：0
|
作者：
Tseng, Cheng-Hao
Hsu, Yao-Chun
Chang, Chi-Yang
Lin, Chih-Wen
Lin, Jaw-Town
Mo, Lein-Ray
机构：
来源：
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY | 2015年 / 13卷 / 07期
关键词：
D O I：
10.1016/j.cgh.2015.04.148
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：E117 / E117
页数：1
相关论文
共 50 条
  • [31] Pegylated interferon and ribavirin treatment for hepatitis C virus infection
    Palumbo, Emilio
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2011, 2 (01) : 39 - 45
  • [32] Effectiveness of sofosbuvir/pegylated-interferon plus ribavirin in treatment of hepatitis C virus genotype 4 patients
    Abdel-Moneim, Adel
    Abood, Alaa
    Abdel-Gabaar, Mohamed
    Zanaty, Mohamed I.
    Ramadan, Mohamed
    CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2018, 4 (03) : 191 - 196
  • [33] Iatrogenic hyperpigmentation in chronically infected hepatitis C patients treated with pegylated interferon and ribavirin
    Lin, Jennifer
    Lott, Jason P.
    Amorosa, Valerianna K.
    Kovarik, Carrie L.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 60 (05) : 882 - 883
  • [34] PEGYLATED INTERFERON ALPHA PLUS RIBAVIRIN TREATMENT OF CHRONIC HEPATITIS C IN PSORIATIC PATIENTS
    Tomasiewicz, Krzysztof
    Modrzewska, Romana
    HEPATOLOGY, 2008, 48 (04) : 907A - 907A
  • [35] Personalized Therapy of Chronic Hepatitis C and B Dually Infected Patients With Pegylated Interferon Plus Ribavirin A Randomized Study
    Yeh, Ming-Lun
    Hsieh, Ming-Yen
    Huang, Ching-I.
    Huang, Chung-Feng
    Hsieh, Meng-Hsuan
    Liang, Po-Cheng
    Lin, Yi-Hung
    Hou, Nai-Jen
    Lin, Zu-Yau
    Chen, Shinn-Cherng
    Huang, Jee-Fu
    Dai, Chia-Yen
    Chuang, Wan-Long
    Yu, Ming-Lung
    MEDICINE, 2015, 94 (42) : e1837
  • [36] Pegylated interferon α2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients
    Moreno, L
    Quereda, C
    Moreno, A
    Perez-Elías, MJ
    Antela, A
    Casado, JL
    Dronda, F
    Mateos, ML
    Bárcena, R
    Moreno, S
    AIDS, 2004, 18 (01) : 67 - 73
  • [37] Treatment of hepatitis C virus genotype 2 and 3 with pegylated interferon plus ribavirin - Reply
    Zeuzem, S
    JOURNAL OF HEPATOLOGY, 2005, 42 (02) : 276 - 277
  • [38] Personalized Therapy of Chronic Hepatitis C and B Dually Infected Patients With PEGylated Interferon Plus Ribavirin: A Randomized Study
    Yeh, M. L.
    Huang, C. F.
    Huang, C. I.
    Hsieh, M. Y.
    Huang, J. F.
    Dai, C. Y.
    Chuang, W. L.
    Yu, M. L.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (07) : 1384 - 1384
  • [39] The impact of pegylated interferon and ribavirin combination treatment on lipid metabolism and insulin resistance in chronic hepatitis C patients
    Jung, Hee Jae
    Kim, Young Seok
    Kim, Sang Gyune
    Lee, Yun Nah
    Jeong, Soung Won
    Jang, Jae Young
    Lee, Sae Hwan
    Kim, Hong Soo
    Kim, Boo Sung
    CLINICAL AND MOLECULAR HEPATOLOGY, 2014, 20 (01) : 38 - 46
  • [40] Low response to pegylated interferon plus ribavirin in HIV-infected patients with chronic hepatitis C treated with abacavir
    Vispo, Eugenio
    Barreiro, Pablo
    Pineda, Juan A.
    Mira, Jose A.
    Maida, Ivana
    Martin-Carbonero, Luz
    Rodriguez-Novoa, Sonia
    Santos, Ignacio
    Lopez-Cortes, Luis F.
    Merino, Dolores
    Rivero, Antonio
    Soriano, Vincent
    ANTIVIRAL THERAPY, 2008, 13 (03) : 429 - 437
12345